IDMED

🎉 𝐖𝐫𝐚𝐩𝐩𝐢𝐧𝐠 𝐔𝐩 𝐭𝐡𝐞 𝐘𝐞𝐚𝐫 𝐢𝐧 𝐟𝐢𝐠𝐮𝐫𝐞𝐬! 🔢 2024 has been a year to remember at IDMED! Here are some highlights that made it truly remarkable: ⬆️ 𝟓𝟒𝟖 ToFscan in 1 order: Our largest single order ever, a testament to the trust our clients place in our technology 📅 𝟐𝟎 congresses where our products were showcased and we engaged with the medical community 📍𝟏𝟔 years of presence in operating rooms worldwide 🌍 𝟔 new countries distributing our products, expanding our reach worldwide. 🔵⚪🔴 𝟏𝟎𝟎% french made products - Proudly designed and manufactured in France, maintaining the highest standards ➡️ And 𝐭𝐡𝐨𝐮𝐬𝐚𝐧𝐝𝐬 of new patients who benefited from our products, making a tangible difference in healthcare outcomes. As we close out 2024, we're filled with pride for our achievements and anticipation for the opportunities ahead. 🙏 We thank all our partners, clients, and team members for being an integral part of our journey. 𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐀𝐡𝐞𝐚𝐝 As we gear up for 2025, we remain driven by our mission to innovate, collaborate, and make a meaningful impact in the medical field. Wishing everyone a joyful holiday season🎄☃️ #Teamwork #Innovation #Sustainability #MedicalDevices #anesthesia #ICU

𝐏𝐮𝐩𝐢𝐥𝐥𝐨𝐦𝐞𝐭𝐫𝐲: 𝐀 𝐊𝐞𝐲 𝐓𝐨𝐨𝐥 𝐟𝐨𝐫 𝐈𝐧𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐂𝐚𝐫𝐞 𝐔𝐧𝐢𝐭𝐬 𝐰𝐢𝐭𝐡 𝐀𝐥𝐠𝐢𝐒𝐜𝐚𝐧® 🚨𝐅𝐫𝐨𝐦 𝐀𝐧𝐞𝐬𝐭𝐡𝐞𝐬𝐢𝐚 𝐭𝐨 𝐈𝐧𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐂𝐚𝐫𝐞: 𝐏𝐮𝐩𝐢𝐥𝐥𝐨𝐦𝐞𝐭𝐫𝐲 𝐢𝐬 𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐬𝐢𝐧𝐠 𝐏𝐚𝐢𝐧 𝐀𝐬𝐬𝐞𝐬𝐬𝐦𝐞𝐧𝐭. The 𝐀𝐥𝐠𝐢𝐒𝐜𝐚𝐧® pupillometer has been an established tool in anesthesia for managing nociception under general anesthesia. Now, its role in intensive care units (ICUs) is becoming even more critical. A recent cross-sectional study by Y. López-De-Audícana et al. highlights the unique contributions of the Pupillary Dilation Response (PDR) in assessing nociceptive pain in mechanically ventilated, sedated patients. 𝐊𝐞𝐲 𝐟𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐬𝐭𝐮𝐝𝐲: 🔹Traditional tools, such as behavioral pain scales (BPS, ESCID) and vital signs, showed limited sensitivity in detecting pain, particularly in patients unable to communicate. 🔹The 𝐀𝐥𝐠𝐢𝐒𝐜𝐚𝐧®detected nociceptive responses even when behavioral indicators suggested no pain, emphasising its sensitivity. 🔹The PDR demonstrated strong agreement with behavioral scales for no-pain scenarios (90%+), but disagreement arose during high-intensity stimuli, uncovering potential under-diagnosed pain cases. 💡 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲: While 𝐀𝐥𝐠𝐢𝐒𝐜𝐚𝐧® has already proven its effectiveness in anesthesia, this study underlines its transformative potential in ICUs, enabling more precise nociception management and improving patient outcomes. 📖  𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐬𝐭𝐮𝐝𝐲: Behavioral pain scales, vital signs, and pupilometry to pain assessment in the critically ill patient: A cross-sectional study. https://lnkd.in/dcy46yVt #MedicalInnovation #ICU #Pupillometry #PainManagement #IDMED #AlgiScan

📅 Jour 9 – Calendrier de l’avent du Dispositif Médical par le SNITEM : focus sur l'anesthésie-réanimation : https://lnkd.in/gEAmzp_2 Merci au SNITEM pour cette belle initiative et pour mettre en lumière les innovations du secteur. 🔎Surveiller la douleur en anesthésie ou en réanimation a longtemps été considéré comme une utopie. Comme le souligne le SNITEM dans son initiative « 1 jour 1 secteur », la complexité réside dans l’incapacité des signaux de douleur à atteindre le cerveau chez les patients sous anesthésie générale, rendant la nociception difficile à monitorer. ➡️Chez IDMED, nous sommes fiers de contribuer à transformer cette utopie en réalité grâce à l'AlgiScan. 🚦Équipé du score PPI (Pupillary Pain Index), notre dispositif offre enfin une solution fiable pour mesurer la nociception, à la fois en anesthésie et en réanimation. Une avancée majeure qui permet d’optimiser la prise en charge des patients sédatés et d’améliorer leur confort. https://lnkd.in/dB_QNDeP Ce progrès illustre parfaitement comment les dispositifs médicaux repoussent les limites et ouvrent de nouvelles perspectives en médecine. #IDMED #AlgiScan #DispositifsMédicaux #Innovation #Anesthésie #Réanimation #Nociception 📅Day 9 – Medical Device Advent Calendar by the French Healthcare association SNITEM: Spotlight on Anesthesia and Intensive Care https://lnkd.in/gEAmzp_2 Thank you to SNITEM for this wonderful initiative and for highlighting the innovations driving our industry forward! 🔎Monitoring pain in anesthesia or intensive care was long considered a utopia. As highlighted by SNITEM’s initiative "1 Day 1 Sector", the challenge lies in the inability of pain signals to reach the brain in patients under general anesthesia, making nociception difficult to assess. ➡️At IDMED, we are proud to help turn this utopia into reality with the AlgiScan. 🚦Equipped with the Pupillary Pain Index (PPI) score, our device provides a reliable solution for measuring nociception in both anesthesia and intensive care. This groundbreaking advancement optimizes care for sedated patients and improves their comfort. https://lnkd.in/ej3ppCZ This innovation perfectly illustrates how medical devices push boundaries and open new possibilities in medicine. #IDMED #AlgiScan #MedicalDevices #Innovation #Analgesia #ICU #Nociception

✨ Festive Vibes at IDMED! ✨ The holiday spirit has officially arrived at IDMED! Today, we decorated our Christmas tree and set the mood for the festive season. A small tradition celebrating the end of another successful year 👏 🌟 Wishing everyone a joyful end of the year ! ---------------------------------------------------------------------- L'esprit des fêtes est officiellement arrivé à IDMED ! Aujourd'hui, nous avons décoré notre sapin de Noël pour sonner le début des festivités. Une petite tradition qui célèbre la fin d'une année réussie. 👏 🌟 Joyeuses fêtes de fin d'année à tous! #FestiveSeason

Expanding Our Reach in Latin America! 🌎 We are thrilled to share that our talented Clinical Application Engineer, Léa Wattiez, visited some of our partners in Latin America over the past 10 days: Dräger Brazil, Dräger Mexico and Dräger Colombia. 🔬 She conducted insightful training sessions for the Dräger sales team, showcasing the features of ToFscan, our TOF monitor, and its potential to improve patient care in the region. ➡️ A big thank you to the Dräger teams for their warm hospitality and commitment to spreading the word about our innovative solutions. We look forward to even greater collaboration in the future! #ToFscan #NMTmonitoring #ClinicalApplications #HealthcareInnovation #SalesTraining #LatinAmerica #MedicalTechnology #TOFmonitor

👋 Le congrès ANARLF a commencé aujourd'hui à l'Université Lumière Lyon 2. Nous sommes présents pour répondre à toutes vos questions sur notre pupillomètre quantitatif : Le NeuroLight 👁️ ➡️ Une conférence animée par le professeur Jean-Francois Payen a également attiré notre attention : "Pupillométrie et pronostication post-ACR"- Mardi 26 Novembre à 11h30 Nous vous attendons nombreux! #pupillometrie #neuroréanimation #neuroanesthésie #QPi #quantitativepupillometry

🔊IDMED au congrès ANARLF 2024 à Lyon ! Nous sommes ravis d'annoncer notre participation au congrès ANARLF qui se tiendra les 25 et 26 novembre 2024 à Lyon. ➡ Venez découvrir nos solutions innovantes : NeuroLight – pour mesurer la réactivité pupillaire et suivre l'état neurologique des patients. AlgiScan – pour objectiver l'analgésie et optimiser les doses d'opioïdes. A ne pas manquer: 📅 Mardi 26 novembre à 11h30 📌 Sujet : "Pupillométrie et pronostication post-ACR" 👨⚕️ Intervenant: Pr Jean-Francois Payen Rencontrez notre équipe et explorez comment nos technologies contribuent à l’amélioration des soins.🏥 📍 Nous vous attendons sur notre stand ! #IDMED #ANARLF2024 #Pupillométrie #InnovationMédicale #NeuroLight #AlgiScan

🔬 Enhancing Neurological Monitoring with NeuroLight’s Transparent QPi Score 🌟 At IDMED, transparency is at the heart of our innovations. The NeuroLight’s QPi score is our flagship feature, designed to simplify the assessment of the Pupillary Light Reflex and provide clinicians with a clear, reliable and easy tool for tracking neurological status over time. We understand that clinicians value both simplicity and detail. That’s why, in addition to the QPi score, NeuroLight offers full access to the pupillary light reflex curve, including key parameters like baseline pupil size, constriction amplitude, or reaction latency. These metrics are available to complete the diagnosis when needed, giving clinicians the confidence to trust the data and make informed decisions. Unlike other tools that may operate as a “black box,” the IDMED approach is fully transparent. We believe in equipping clinicians with both the simplicity of the QPi score and the detailed data behind it—because trust is built on transparency. #NeurologicalMonitoring #Prognostication #QPiScore #MedicalInnovation #NeuroLight #Pupillometry #Healthcare #Transparency

🌟 Showcasing Neurolight at EuroNeuro 2024: Advancing Neurological Monitoring with Full Transparency 👁 We’re thrilled to present our NeuroLight Quantitative Pupillometer to the medical community here at EuroNeuro at booth 10 with the strong support of our local partner Medigas Italia. Beyond its essential clinical value for neurological prognostication, Neurolight stands out for its dedication to total transparency — a principle that aligns with the highest standards in medicine. 🔢 Our QPi score, which gives a quick and precise interpretation of the Pupillary Light Reflex, has been developed in accordance with the core medical principle of transparency. We’ve designed it so that clinicians can fully understand and verify its functionality, without being restricted by intellectual property rights that could hinder their work or research. At IDMED, we’re committed to empowering healthcare professionals with tools that put patient care and clarity first. 📆 Don't miss the hands-on sessions on pupillometry on all three days, where you will have the occasion to try NeuroLight. See the programme here:  https://lnkd.in/dA6kEai7 Looking forward to sharing and connecting with fellow experts! Euro Neuro - Update on Neuroanesthesia & Neuro-Intensive Care #IDMED #EuroNeuro2024 #Neurolight #MedicalTransparency #QPi #pupillometry

📢IDMED will be present at the Euroneuro 2024 congress in Florence, Italy, from 29 to 31 October! Join us at booth number 10 to discover our innovative quantitative pupillometer, the NeuroLight. ✨ 📅Don't miss the hands-on sessions on pupillometry on all three days, where you will have the occasion to try NeuroLight.  See the programme here: https://lnkd.in/gbn-mM4S We look forward to meeting you and discussing the latest advances in neuro critical care. #IDMED #Euroneuro #NeuroLight #Pupillometry #NeuroAnesthesia #Florence2024 #Congress #Innovation #IntensiveCare #Neurology EuroNeuro Brussels